Norethandrolone
Systematic (IUPAC) name | |
---|---|
(17β)-17-ethyl-17-hydroxyester-4-en-3-one
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 52-78-8 |
ATC code | A14AA09 (WHO) |
PubChem | CID: 5858 |
ChemSpider | 5649 |
UNII | P7W01638W6 |
KEGG | D07127 |
Synonyms | Noretandrolone; CB-8022 |
Chemical data | |
Formula | C20H30O2 |
Molecular mass | 302.451 g/mol |
|
|
|
|
(verify) |
Norethandrolone (INN, BAN) (brand names Nilevar, Pronabol), also known as 17α-ethyl-19-nortestosterone, is an anabolic steroid.[1] It was synthesized at G. D. Searle & Company in 1953 and was originally studied as a progestin, along with norethisterone and noretynodrel, but was ultimately not marketed as such.[2][3] In 1955, it was re-examined for testosterone-like activity and was found to have similar anabolic activity to testosterone but only one-sixteenth the androgenic potency.[3][4] The drug was introduced in the United States as an anabolic steroid in 1965 under the trade name Nilevar[5] but was withdrawn from the market in the 1980s due to concerns of cholestatic jaundice.[4] Norethandrolone is now only marketed in Australia, France, and Switzerland, and as with all 17α-alkylated oral steroids, long-term use in high doses may result in elevated liver enzymes and consequently cirrhosis.[6] It is used in the treatment of muscle wasting,[4] patients with severe burns, after severe trauma, and for certain forms of aplastic anemia.
See also
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 3.0 3.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 4.0 4.1 4.2 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>